Skip to main content
PLOS One logoLink to PLOS One
. 2023 Dec 21;18(12):e0295266. doi: 10.1371/journal.pone.0295266

Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, Ethiopia

Tigist Engda 1,*, Belay Tessema 2, Nebiyu Mesifin 3, Anwar Nuru 4, Teshome Belachew 1, Feleke Moges 1
Editor: Balew Arega Negatie5
PMCID: PMC10734908  PMID: 38127993

Abstract

Background

Shiga toxin-producing Escherichia coli O157:H7 (STEC O157:H7) is a zoonotic pathogen that causes diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome worldwide. This study aimed to determine the prevalence, antibiotic susceptibility, and associated risk factors of STEC O157:H7 among diarrheic patients and their cattle.

Methods

A cross-sectional study was conducted among diarrheic patients and their cattle in Amhara National Regional State, Ethiopia from December- 2020 to June- 2022. A total of 1,149 diarrheic patients and 229 cattle were included in the study. STEC O157:H7 detection was done using culture, latex agglutination test, and polymerase chain reaction on diarrheic stool samples and recto-anal mucosal swabs of cattle. Antibiotic susceptibility tests were performed using disk diffusion techniques. Risk factors association were identified using binary and multivariable logistic regression analysis.

Results

The overall prevalence of STEC O157:H7 in diarrheic patients and their cattle was 11.1% (128/1149) and 14.4% (33/229) respectively. High percentage of the study subjects were found in under-five children (34.5%). Age less than 5 (AOR: 4.02, 95%CI:1.608–10.058,P = 0.003), and greater than 64 years old (AOR:3.36, 95% CI:1.254–8.986, P = 0.016), presence of diarrheic patient in the house (AOR:2.11, 95%CI:1.309–3.390, P = 0.002), availability of cattle in the house (AOR:2.52, 95%CI:1.261–5.049, P = 0.009), and habit of consuming raw foods (AOR:4.35, 95%CI:2.645–7.148, P = 0.000) were risk factors. Antibiotic resistance was shown in 109(85.2%), and 31(93.9%) isolates from diarrheic patients and their cattle respectively. The highest levels of antibiotic resistance were found to tetracycline (54.7%, 69.7%) in diarrheic patients and their cattle respectively. Multiple drug resistance was also observed among 56(43.8%) and 11(33.3%) isolates in diarrheic patients and their cattle respectively.

Conclusion

Our study showed high prevalence of STEC O157:H7 in diarrheic patients and their cattle. Therefore, health education should be given to the community on how to care for animals, proper sanitation, and the impact of raw food consumption.

Introduction

Diarrheal disease is a major public health problem responsible for high morbidity and mortality Worldwide. It is among the leading causes of outpatient visits, hospitalization, and the global year of life lost (YLL) in people of all ages [1]. It shares 4% of all deaths and 5% of health losses to disability in the world [2]. It is one of the top ten causes of death, ranking ninth globally, sixth in lower-middle-income countries, and second in low-income countries [3]. Ethiopia ranks fifth with the highest burden of diarrhea and pneumonia in the world [4]. Diarrhea can be caused by different gastrointestinal (GI) pathogens, including viruses, bacteria, and protozoa [5]. Among bacterial pathogens, Escherichia coli (E. coli) is the most common etiological agent that causes moderate-to-severe diarrhea in low-income countries [6]. This group of E. coli is said to be Diarrheagenic E. coli (DEC) and is a significant contributor to diarrheal disease throughout the world [7]. Shiga toxin-producing E. coli O157:H7 is one of Diarrheagenic E. coli [7].

Shiga toxin-producing E. coli O157:H7 is typically a food-borne pathogen causing gastroenteritis and bloody diarrhea, and sometimes it leads to hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), end-stage renal disease (ESRD), and even to death [8].

It is noted that for the first time, STEC O157:H7 emerged as a human pathogen in the USA in the early 1980s, during large-scale outbreaks of hemorrhagic colitis and HUS [9]. Since then, it has been epidemiologically and clinically important worldwide. Around half of human cases are sporadic, with a seasonal pattern favoring spring and summer. Reports showed that the distribution of STEC O157:H7 differs between regions, potentially influencing the incidence and severity of human disease [10].

Shiga toxin-producing E. coli O157:H7 is a zoonotic bacterial pathogen in ruminant animals like cattle. Cattle are the most important reservoir for STEC O157:H7 [11]. However; due to the absence of globotriaosylceramide-3 (Gb3) vascular receptors for Shiga toxin, its colonization to gastrointestinal tracts of cattle is usually asymptomatic [12], and even it cannot be endocytosed and transported to other organs [13]. As a result, it can accumulate in the terminal part of the large intestine and recto-anal junction [14]. Moreover; Shiga toxin-producing E. coli O157:H7 can also be found in water, soil, meat, fruit, and vegetable products that are contaminated with ruminants’ fecal material [15].

The best treatment of STEC O157:H7 infection is supportive care. Such as; balancing fluid levels and electrolytes and monitoring the possible development of microangiopathic complications such as HUS [8]. Antibiotic therapy is considered to be not beneficial as several antibiotics have been observed to induce the expression and release of Shiga toxins [9].

Even though reports were showing the prevalence of STEC O157:H7 among diarrheic patients in Ethiopia [1619], still there is limited information in different regions of the country, particularly in the Amhara National Regional State. Therefore, this study aimed to investigate the distribution and antibiotic susceptibility pattern of STEC O157:H7 among diarrheic patients and their cattle in Amhara National Regional State of Ethiopia.

Materials and methods

Study area and period

The study was conducted in Comprehensive Specialized Hospitals found in Amhara National Regional States, namely Debre-Markose, Felege-Hiwot, Dessie, Debre-Tabor, and University of Gondar Comprehensive Specialized Hospitals from December 2020 to June 2022. Amhara National Regional State is the second most populous region in the country, Ethiopia. The region has a total population of 20,769,985 of those, 3,492, 000 (16.8%) were urban inhabitants [20].

Study design

A cross-sectional study design was used to determine the prevalence of STEC O157:H7, its associated factors, and antimicrobial susceptibility patterns among diarrheic patients and their cattle.

Study population

The source population is all diarrheic patients who had visited the respective Comprehensive Specialized Hospitals for medical services and their cattle. However; These diarrheic patients who are volunteers for the study and fulfill the requirements including giving informed consent and the required amount of stool samples for laboratory analysis and cattle found in the house of STEC O157:H7 positive patients are the study population.

Inclusion and exclusion criteria

All diarrheic patients who had visited the selective Hospitals for medical services during the study period and cattle found in the house of STEC O157:H7 positive diarrheic patients were included. However, patients who did not gave consent to the study, and patients and cattle who were on antibiotics treatment for the last 7 days of data collection, were excluded from the study.

Sample size and sampling techniques

The sample size for diarrheic patients was calculated using the statistical formula [6],

n=Z2xp(1p)d2

where, n = sample size, P = Prevalence in the target population to have STEC O157:H7 (13.9%) (19), Z = Value of standard normal distribution (Z-statistic) at 95% confidence interval (Z = 1.96), d = desired absolute precision (margins of error) for estimating a single population proportion (d = 2% = 0.02), and the final sample size was 1,149.

A simple random sampling technique was used to select the Hospitals. However, the study participants were selected using systematic random sampling techniques. The sample size was proportionally allocated to the selected Hospitals based on the previous case flow. It was calculated by the formula; ni=(Nixn)N, Where ni = sample size allocated for a given site, Ni = total number of diarrheic patients visited in a given site in the last 12 months of data collection (Debre-Markose = 2776, Felege-Hiwot = 2576, Debre-Tabor = 2489, Dessie = 2489, and University of Gondar = 3970), N = total number of diarrheic patients attended in the respective Hospitals in the last 12 months (14,300) and n = the sample size of the study (1,149). Based on this formula, 223, 207,200, 200, and 319 diarrheic patients were allocated to Debre-Markose, Felege-Hiwot, Debre-Tabor, Dessie, and the University of Gondar compressive specialized Hospitals respectively.

In the case of cattle, all cattle found in STEC O157:H7-positive patients’ houses were included in the study and were found to be 229. Other than the wastage of materials, this increases the chance of getting positive cases.

Data collection tools

Questionnaire

A pretested structured questionnaire was used to collect the necessary data. After obtaining written consent and/or assent from each participant, socio-demographic data, clinical information, and information on the availability of cattle and other possible risk factors of diarrheic patients for STEC O157:H7 were collected. The questionnaire was prepared in English using published studies and translated into the local language (Amharic). Once data were collected, responses to each questionnaire were re-translated into English for analysis and report.

Sample collection and transportation

Diarrheic stool sample

After written informed consent and/or assent was obtained, a structured questionnaire was used and completed by laboratory technicians on a face-to-face interview basis. The participants were also asked and guided by the laboratory technicians to give the stool sample. The sample was collected with a clean, detergent-free disposable screw-capped bottle, and labeled with the patient’s code number. On-spot gross examination of stool samples was performed to note the type of diarrhea. Then, about 2 gm of each fecal sample was added to culture tubes containing 10ml tryptone soya broth (TSB) for transportation to the laboratory in a cooler box within 2 hours of collection [21].

Recto anal mucosal swab

Recto-anal mucosal swab (RAMS) sample is more sensitive than fecal sampling for determining the prevalence of STEC O157:H7 in ruminant animals [22]. The Recto-anal mucosal swab was collected before defecation to minimize fecal contamination [23]. It was used aseptically from each cattle by inserting a sterile cotton-tipped swab about 2-3cm into the anus. Using a circular motion, the entire surface of the recto-anal mucosa was swabbed. Each swab was placed into a 5ml culture tube containing 2ml TSB for transportation to the laboratory in a cooler box within 2 hours of collection.

Both tryptone soya broth-enriched samples were stored in a cold box with ice packs to transport to the University of Gondar Microbiology Laboratory and the samples were processed immediately after arrival, otherwise, they were stored at -20°C until processed.

Isolation and characterization of Shiga toxin-producing E. coli O157:H7(S1 File)

The enriched samples were cultured aerobically at 37°C for 24 hours on MacConkey agar (Oxoid, England). After incubation, isolates’ characteristics and reactions on agar media were observed and recorded [24]. Five to ten suspected colonies (pinkish color appearance) were sub-cultured on a separate nutrient agar (Oxoid, England) and confirmed by the biochemical tests.

The Biochemical tests were performed on pink-color colonies to differentiate E. coli. The typical biochemical reactions that are considered as E. coli are positive for the Indole test, negative on Simon’s citrate agar, and urease test, and fermentation of lactose and glucose using Triple Sugar Iron (TSI) with the production of acid and without hydrogen sulfide (H2S) production [21,25,26].

The identified E. coli isolates were sub-cultured on sorbitol MacConkey agar containing cefixime and tellurite (CT-SMAC) (Oxoid, England) media at 37°C for 24 hours to differentiate Shiga toxin-producing E. coli from other E. coli strains. Sorbitol fermenters (pinkish colonies) were considered as non-O157:H7 E. coli strains whereas the non-sorbitol fermenting isolates (colorless colonies) were supposed to be as presumptively confirmed as Shiga toxin-producing E. coli O157:H7 strains [27].

Serological test

All non-sorbitol fermenting colonies from the cefixime and tellurite-containing sorbitol-MacConkey agars (CT-SMAC) were serologically confirmed using RIMTM E. coli O157:H7 latex test (R24250, Oxoid, Basingstoke, Hants, England). RIMTM E. coli O157:H7 latex contains 3 reagents [28]. The particles in each reagent are coated with a different antibody: one against STEC serotype O157, another against STEC serotype H7, and the third with normal rabbit globulin to serve as control latex. A drop of Latex was dispensed into the circle of the reaction card. Using a loop, 10 separate colonies were taken and added into the circle which contained latex reagent. The test latex particles were mixed with fresh colonies of STEC O157:H7, which is positive by CT-SMAC, and in immunochemical reactions, those undergoing agglutination within a minute were registered as positive for STEC O157:H7. The absence of agglutination indicates that the test isolates were not STEC O157:H7. The control Latex reagent identifies non-specific reactions [28].

Polymerase chain reaction (PCR) analysis

Deoxyribonucleic acid (DNA) extraction of the isolate was done by boiling and centrifugation. The isolates grown in nutrient broth were harvested, centrifuged at 12,000 rpm for 10 minutes, and the supernatant was discarded. The sediment was then washed with 1.0ml distilled water and vortexed. The isolate sediment was lysed by boiling in a water bath at 95°C for 10 minutes and the lysate was then centrifuged. Finally, the supernatant was used as a DNA template for PCR [29].

Amplification of rfb O157 and flic H7 genes

Isolates were confirmed as STEC O157:H7 by using specific primers for rfb O157 (292 bp) [30,31] and flic H7 genes (625bp) [30,32]. Amplification of rfb O157 and flic H7 are genes encoding for the O157 somatic and H7 flagellar antigens respectively. These were estimated by using adapted primers [31,32] (Table 1). The amplification mixture contains 5μl platinum super II green master mix (Taq DNA polymerase, dNTPs, MgCl2, and reaction buffer at optimal buffer concentration for efficient amplification of DNA templates by PCR, 1.25μl purified DNA, 0.25μl of each forward and reverse primer, then the volume was completed to 3.25μl by deionized water. A negative control was performed by adding 10μl of sterile deionized water and a positive control was performed by adding 1.25μl of known DNA sample (STEC O157:H7; ATCC 43895). All tubes were centrifuged in a microcentrifuge for 10 seconds. Then for the amplification reaction, PCR tubes were transferred to the thermocycler. Polymerase chain reaction conditions consisted of an initial 98°C denaturation step for 1 minute followed sequentially by 35 cycles of 98°C for 10 seconds, 53°C for 10 seconds, and 72°C for 45 seconds. The final extension cycle was followed at 72°C for 5 minutes.

Table 1. Oligonucleotide sequences of the primers used in PCR amplification.
Target gene Primers Nucleotide sequence (5’-3’) Amplicon size (bp)
rfbO157 rfb-F GTGTCCATTTATACGGACATCCATG 292
rfb-R CCTATAACGTCATGCCAATATTGCC 292
flic H7 flic-F GCGCTGTCGAGTTCTATCGAGC 625
flic-R CAACGGTGACTTTATCGCCATTCC 625

Key: rfb-F = Forward primers, rfb-R = Reverse primers, rfbO157 = rfb O157 gene encoding for the O157 somatic antigens, flicH7 = flic gene encoding H7 flagellar antigen.

Agarose gel electrophoresis

Amplified PCR products were analyzed by gel electrophoresis in 1% agarose gel. The gels were stained with 0.5μl of ethidium bromide (EtBr) per ml and electrophoresed at 120v for 50 minutes using 1xTris-borate-EDTA (TBE) buffer and used a marker DNA ladder of 100bp. The products were visualized with UV illumination and imaged with a gel documentation system (Fig 1).

Fig 1. Agarose Gel Electrophoresis of amplified genes of STEC O157: H7.

Fig 1

M represents the molecular ladder (100bp), lane2 is positive control, and lane6 is negative control. Lane 1,3,4,5,7,8,9,10, &11 represents the samples. Samples on lane 7 and 8 did not show any amplification of the target genes while lanes 1, 3, 4, 5, 9, 10, and 11 showed amplification of rfbO157 = rfb O157 (292bp) gene encoding for the O157 somatic antigens, flicH7 = flic gene (625bp) encoding H7 flagellar antigen as evidenced by the presence of bands. Sample on lane 1 amplified only flicH7 = flic gene (625bp).

Antimicrobial susceptibility test

Antimicrobial susceptibility testing was done on Mueller-Hinton agar (Oxoid, England) using the disk diffusion technique according to the Kirby-Bauer method [17]. The antimicrobial agents tested were amoxicillin/clavulanate (20/10μg), ceftazidime (30μg), ceftriaxone (30μg), cefixime (5μg), cefuroxime (30μg), sulfamethoxazole/trimethoprim (1.25/23.75μg), ciprofloxacin (5μg), norfloxacin (10μg), tetracycline (30μg), gentamycin (10μg), and chloramphenicol (30μg).

Bacterial inocula were prepared by suspending 4 to 5 freshly grown STEC O157:H7 colonies in 3-5ml sterile physiological saline and turbidity was adjusted to a 0.5 McFarland standard [17]. The sterile cotton swab was dipped, rotated several times, pressed against the wall of the test tube and then swabbed over the entire surface of the Muller-Hinton agar. After the plates were dried, antibiotic-impregnated disks (Oxoid, England) were placed on the surface of the inoculated plates using sterile thumb forceps. The plates were incubated aerobically at 37°C for 24 hours. Finally, the diameter of the inhibition zone formed around each disk was measured on the black surface using a transparent ruler placed over the plates and recorded. Following CLSI guidelines, the antibiotic susceptibility profile was classified as sensitive (S), intermediate (I), and resistant (R) [3537].

Moreover; Multiple Drug Resistance, resistance to at least three antibiotic classes, profiles were determined against the commonly used classes of antimicrobials, Cephem class (ceftriaxone, ceftazidime, cefixime, cefuroxime), β-lactam combination class (amoxicillin/clavulanate), Aminoglycoside class (gentamycin), Fluoroquinolone class (ciprofloxacin, norfloxacin), Tetracycline class (tetracycline), Folate pathway inhibitors (sulfamethoxazole/trimethoprim), Phenicols class (chloramphenicol) [33].

Study variables

Dependent variables:—STEC O157:H7 associated diarrhea

Independent variables:- are explanatory variables that include socio-demographic behavioral and environmental factors concerning diarrheic patients (age, sex, residence, another diarrheic person in the house, duration of diarrhea, frequency of diarrhea, stool appearance, drinking water source, place of defecations, history of hand washing habit, history of consuming raw food, availability of cattle in the house and sharing of home with cattle), and socio-demographic behavioral factors related to cattle found in the diarrheic patient (age, residence, water source, washing habit of cattle, home of cattle, type of cattle food, purpose of cattle).

Quality control

The questionnaire was pretested for a week before data collection started. The training was prepared for laboratory technicians to ensure their data collection techniques. Supervision was made at regular times. The questionnaires were checked their completeness and collected at regular times. Appropriate standard strains, E. coli (ATCC 25922), and STEC O157:H7 (ATCC 43895) were used as control strains. The test kits of STEC O157:H7 have their quality control material that can be run in parallel with samples, and all test procedures were done strictly following the manufacturer’s instructions.

Data analysis

Data were checked for completeness and entered and analyzed using IBM SPSS Statistics version 25. Descriptive statistics aimed to summarize the study participants’ characteristics across the outcome variable were used. The association between the outcome variable and each independent variable was analyzed using bi-variable and multi-variable logistic regression models.

The independent variable which had a significant association with the STEC O157:H7 infection in diarrheic patients at a ≤ 0.2 in the bi-variable logistic regression model was entered into the multivariable logistic regression model to identify the association of risk factors with STEC O157:H7 infection. The assumption of goodness of the model was checked by the Hosmer-Lemeshow test (p = 0.071). The association between the outcome and the independent variable was calculated by using the adjusted odds ratio at a p-value ≤ 0.05 and 95% Confidence Interval.

Data were summarized using frequency tables. For descriptive statistics, standard deviation (SD), frequencies, and percentages were used. In the case of categorical variables, univariable and multivariate analysis with a 95% confidence interval (CI) was performed to measure their association, and a p-value ≤ 0.05 was considered statistically significant.

Ethical statement

We obtained ethical clearance from the ethical review board of the University of Gondar (V/P/RCS/051/69). After clearly explaining the aim of the study, the confidentiality of their information, and their full right to refuse or drop participating in the research, all diarrheic patients or their caregiver signed their consent. Participants’ woreda, kebele, specific gote, and phone numbers were registered in the questionnaire. We communicated with STEC O157:H7- positive patients to give information about the disease and to collect cattle samples from those who had cattle in their houses. We tried to reach all cattle found in positive diarrheic patients houses through the developmental agency workers and signed their consent.

Results

Socio-demographic characteristics of the diarrheic patients

A total of 1149 diarrheic patients were included in this study. The samples distribution was 441(38.4%) from University of Gondar, 207(18.0%) from Felege-Hiwot, 223(19.4%) from Debre-Markose, 200(17.4%) from Debre-Tabor, and 78(6.8%) from Dessie Comprehensive Specialized Hospitals. Of the total diarrheic patients, 613(53.4%) were male and 396(34.5%) were children under five. A high percentage of the study participants, 719(62.6%) were urban residents (Table 2).

Table 2. Socio-demographic characteristics of diarrheic patients.

Socio-demographic characteristics Category Frequency
N (%)
STEC O157:H7
Positive N (%) Negative N (%)
Age <5 years 396 (34.5) 56 (4.8) 340 (29.6)
5–14 years 229 (19.9) 24 (2.1) 205 (17.8)
15–24 years 170 (14.8) 7 (0.6) 163 (14.2)
25–64 years 142 (12.4) 11 (1.0) 131 (11.4)
> 64 years 212 (18.4) 30 (2.6) 182 (15.8)
Sex Male 613 (53.4) 67 (5.8) 546 (47.6)
Female 536 (46.6) 61(5.3) 475 (41.3)
Marital status Single 311 (27.1) 35 (3.0) 276 (24.0)
Married 784 (68.2) 88 (7.7) 696(60.6)
Divorced 54 (4.7) 5 (0.4) 49 (4.3)
Residence Urban 719 (62.6) 62 (5.4) 657 (57.2)
Rural 430 (37.4) 66 (5.7) 364 (31.7)
Educational
Status
Illiterate 394 (34.3) 54 (4.7) 340 (29.6)
Read and write 259 (22.6) 29 (2.5) 230 (20.0)
Primary school completed 252 (21.9) 20 (1.7) 232 (20.2)
Secondary school completed 123 (10.7) 16 (1.4) 107 (9.3)
University graduated 121 (10.5) 9 (0.8) 112 (9.8)
Occupation Farmer 165 (14.4) 13 (1.1) 152 (13.2)
Housewife 288 (25.1) 44 (3.8) 244 (21.3)
Merchant 308 (26.8) 32 (2.8) 276 (24.0)
Student 63 (5.5) 10 (0.9) 53 (4.6)
Government Employer 170 (14.8) 15 (1.3) 155 (13.5)
Daily laborer 92 (8.0) 9 (0.8) 83 (7.2)
Private employer 63 (5.5) 5 (0.4) 58 (5.1)
Monthly income < 500 birrs 395 (34.4) 53 (4.6) 342 (29.8)
500–1000 birr 384 (33.4) 48 (4.2) 336 (29.2)
>1000 birr 370 (32.2) 27(2.3) 343 (29.9)
Another diarrheic person in the house No 541(47.1) 42 (3.6) 499 (43.5)
Yes 608(52.9) 86 (7.5) 522 (45.4)

Prevalence of Shiga toxin-producing Escherichia coli O157:H7

In diarrheic patients, 1149 diarrheic stool samples were collected following the standard procedure. The collected diarrheic stool samples were bloody, mucoid, and watery: 420(36.6%), 390(33.9%), and 339(29.5%), respectively. Of the total stool samples, 128 stool samples were positive for STEC O157:H7 with rfb O157 and flic H7 genes in PCR with agarose gel Electrophoresis tested (Table 1). As a result, the overall prevalence was 11.1% (95% CI: 0.09–0.13).

The highest percentage of STEC O157:H7 was detected among diarrheic patients who had bloody diarrhea (5.2%), 1 to 3 days duration of diarrhea (5.1%), 4 to 9 times diarrheal frequency (6.7%), patients history for hand washing habit in before and after eating (9.1%), and history of consuming raw food (8.3%) (Table 3).

Table 3. Clinical manifestation and behavioral characteristics of diarrheic patients.

Clinical manifestation and behavioral characteristics Category Frequency
N (%)
STEC O157:H7
Positive N (%) Negative N (%)
Duration of diarrhea 1–3 days 457 (39.8) 58 (5.1) 399 (34.7)
4–6 days 421 (36.6) 43 (3.7) 378 (32.9)
7–10 days 271(23.6) 27 (2.3) 244 (21.3)
Frequency of diarrhea ≤ 3 724 (63.0) 41 (3.6) 683 (59.4)
4–9 384(33.4) 77 (6.7) 307(26.7)
> 9 41(3.6) 10 (0.9) 31(2.8)
Stool appearance Watery 339 (29.5) 20 (1.7) 319 (27.8)
Mucoid 390 (33.9) 48(4.2) 342(29.8)
Bloody 420 (36.6) 60 (5.2) 360 (31.3)
Drinking water source Tap 708(61.6) 59 (5.1) 649 (56.5)
Water well 404(35.2) 64 (5.6) 340 (29.6)
Surface 37(3.2) 5 (0.4) 32 (2.8)
Diarrheic patient
water treatment
No 456 (39.7) 75 (6.5) 381(33.2)
Filtering 391(34.0) 27 (2.3) 364 (31.7)
Aqua tab or Water guard 161(14.0) 19(1.6) 143(12.4)
Boiling 141(12.3) 8 (0.7) 133 (11.6)
Place of defecations Modern toilet 217(18.9) 16 (1.4) 201(17.5)
Traditional toilet 583(50.7) 51(4.4) 532(46.3)
Open field 160(13.9) 30 (2.6) 130 (11.3)
Public toilet 189(16.5) 31 (2.7) 158 (13.8)
History of hand
washing habit
Before eating and after the toilet 249 (21.7) 13 (1.1) 236 (20.5)
Before preparing food and washing house utilities 168 (14.6) 10 (0.9) 158(13.8)
Before and after eating 732 (63.7) 105 (9.1) 627 (54.6)
History of consuming raw food Yes 604 (52.6) 96 (8.3) 508 (44.2)
No 545 (47.4) 32 (2.8) 513 (44.6)
Availability of cattle in the house Yes 187 (16.3) 53 (4.6) 134 (11.)
No 962 (83.7) 74 (6.4) 888 (77.3)
Sharing of home with cattle Yes 103 (9.0) 33 (2.9) 70(6.1)
No 1046 (91.0) 95 (8.2) 951(82.8)

Only a small proportion of the study participants, 187(16.3%) had a total of 561 cattle in their house (Table 3). However, from 187 diarrheic patients, only 53 were positive for STEC O157:H7 and had 229 cattle. Of these cattle, 123, 47, and 59 were cows, oxen and calves respectively. Samples from these cattle were collected by following standard protocol [23].

The recto mucosal swab samples of these 33 cattle, (18 cows, 6 oxen and 9 calves) were PCR positive for STEC O157:H7 with rfb O157 and flic H7 genes (Table 1). As a result, the overall prevalence of STEC O157:H7 in cattle was 14.4% (95%CI:0.39–0.52).

Associated risk factors for Shiga toxin-producing Escherichia coli O157:H7

In this study, different variables were considered during the bivariate analysis. These variables were taken as a possible risk factor for STEC O157:H7 infections. Comparatively a higher prevalence of STEC O157:H7 was found among under 5 children and over 64 years of age. Moreover; patients who were rural residents, had mucoid and bloody diarrhea, had low monthly income, were poor in regular hand washing activities before and after eating, had the habit of consuming raw food, and had cattle were risk factors for STEC O157:H7.

In multivariable analysis, diarrheic patients of under-five children were 4(AOR = 4.02, 95%CI; 1.608–10.058, P = 0.003) times and old ages greater than 64 years were 3(AOR = 3.357, 95% CI: 1.254–8.986, P = 0.016) times more likely to have STEC O157:H7 associated diarrhea than other age groups (Table 4).

Table 4. Associated risk factors of Shiga toxin-producing E. coli O157:H7 among diarrheic patients.

Variables Category COR (95% CI) P-value AOR (95% CI) P-value
Age <5 years 3.835(1.710–8.601) 0.001 4.02(1.608–10.058) 0.003
5–14 years 2.726(1.146–6.486) 0.023 2.39(0.905–6.337) 0.079
15–24 years 1.00 1.00
25–64 years 1.955(0.737–5.185) 0.178 1.63 (0.546–4.867) 0.381
> 64 years 3.838(1.642–8.975) 0.002 3.36 (1.254–8.986) 0.016
Residence Urban 1.00 1.00
Rural 1.921(1.328–2.780) 0.001
Monthly income <500 birr 1.969(1.210–3.204) 0.006 1.55 (0.842–2.846) 0.160
500–1000 birr 1.815(1.106–2.977) 0.018 2.39 (1.285–4.456) 0.006
>1000 birr 1.00 1.00
Another diarrheic patient in the house No 1.00 1.00
Yes 1.957(1.327–2.888) 0.001 2.11(1.309–3.390) 0.002
Frequency of diarrhea/ day ≤ 3 1.00 1.00
4–9 4.178(2.795–6.247) 0.000 4.34 (2.730–6.902) 0.000
> 9 5.374(2.465–11.715) 0.000 4.23 (1.669–10.724) 0.002
Drinking water source Tap 1.00
Water well 2.071(1.420–3.020) 0.000 1.294(0.643–2.604) 0.470
Surface 1.719(0.645–4.577) 0.278 1.983(0.543–7.247) 0.300
Drinking water treatment No 3.273(1.538–6.964) 0.002 2.228(0.704–7.048) 0.173
Filtering 1.233(0.547–2.762) 0.614 1.173(0.426–3.228) 0.757
Water guard 2.093(0.881–4.973) 0.095 2.945(0.985–8.805) 0.053
Boiling 1.00
Place of defecation Modern 1.00
Traditional Latrine 1.204(0.671–2.161) 0.533
Open field 2.899(1.520–5.529) 0.001
Public latrine 2.465(1.302–4.667) 0.006
History of hand washing habit Before eating and after the toilet 1.00 1.00
Before preparing food and washing house utilities 1.149(0.492–2.685) 0.748 0.783(0.296–2.073) 0.623
After eating 3.040(1.676–5.514) 0.000 3.55 (1.766–7.143) 0.000
History of consuming raw food Yes 3.030(1.994–4.604) 0.000 4.35 (2.645–7.148) 0.000
No 1.00 1.00
Availability of cattle in the house Yes 4.872(3.281–7.234) 0.000 2.52(1.261–5.049) 0.009
No 1.00 1.00
Sharing of home with cattle Yes 4.719(2.966–7.500) 0.000 2.03(0.892–4.614) 0.092
No 1.00

Diarrheic patients who had an experience of consuming raw foods were 4(AOR = 4.35, 95% CI: 2.645–7.148, p = 0.000) times more likely to have STEC O157:H7 associated diarrhea than their counterparts. Those diarrheic patients who had cattle in their house were 3(AOR = 2.52 95% CI: 1.261–5.049, P = 0.009) times more likely to have STEC O157:H7 associated diarrhea than patients who did not have (Table 4).

Antimicrobial susceptibility profile of Shiga toxin-producing E. coli O157:H7

All STEC O157:H7 isolates in diarrheic patients and their cattle were subjected to an antimicrobial susceptibility test with 11 commonly prescribed antimicrobial drugs. Antibiotic resistances were shown in 109(85.2%) and 31(93.9%) STEC O157:H7 isolates from diarrheic patient and their cattle respectively.

Shiga toxin-producing E. coli O157:H7 isolates exhibited high level of antibiotic resistance to tetracycline 70(54.7%), amoxicillin/clavulanate 68(53.1%), and sulfamethoxazole/ trimethoprim 56(43.8%) in diarrheic patients, and tetracycline 23(69.7%), Amoxicillin/ clavulanate, 15(45.4%), Sulfamethoxazole/trimethoprim 16(48.5%) in cattle. However; low level of antibiotic resistance was found in chloramphenicol 12(9.4%), norfloxacin 12(9.4%), and ciprofloxacin 16(12.5%) in diarrheic patients, and chloramphenicol 1(3.03%), norfloxacin 2(6.1%) and ciprofloxacin 4(12.1%) in cattle (Table 5).

Table 5. Antibiotic susceptibility profiles for STEC O157:H7 isolates from diarrheic patients and their cattle.

Antibiotic STEC O157:H7 from diarrheic Patients (N = 128) STEC O157:H7 from Cattle
(N = 33)
S
N (%)
I
N (%)
R
N (%)
S
N (%)
I
N (%)
R
N (%)
Amoxicillin/
Clavulanate
48 (37.5) 12 (9.4) 68 (53.1) 12(36.4) 6 (18.2) 15 (45.4)
Ceftazidime 106 (82.8) 4 (3.1) 18 (14.1) 25 (75.7) 2 (6.1) 6 (18.2)
Ceftriaxone 99 (77.3) 12 (9.4) 17 (13.3) 18 (54.5) 9 (27.3) 6 (18.2)
Cefixime 101 (78.9) 8 (6.3) 19 (14.9) 17 (51.5) 10 (30.3) 6 (18.2)
Cefuroxime 92 (71.9) 2 (1.6) 34 (26.5) 22 (66.7) 2 (6.0) 9 (27.3)
Sulfamethoxazole/ Trimethoprim 67 (52.3) 5 (3.9) 56 (43.8) 15 (45.4) 2(6.1) 16 (48.5)
Ciprofloxacin 103 (80.5) 9 (7.0) 16 (12.5) 24(72.7) 5 (15.2) 4 (12.1)
Norfloxacin 112 (87.5) 4 (3.1) 12 (9.4) 28(84.9) 3 (9.0) 2 (6.1)
Tetracycline 51 (39.8) 7 (5.5) 70 (54.7) 9 (27.3) 1(3.0) 23 (69.7)
Gentamycin 63 (49.2) 10 (7.8) 55 (43) 10 (30.3) 17 (5.5) 6 (18.2)
Chloramphenicol 109 (85.1) 7 (5.5) 12 (9.4) 28 (84.9) 4(12.1) 1 (3.0)

Key: AMC: Amoxicillin/Clavulanate, CAZ: Ceftazidime, CTR: Ceftriaxone, CFM: Cefixime, CXM: Cefuroxime, SXT: CIP: Ciprofloxacin, NX: Norfloxacin, TC: Tetracycline, CN: Gentamycin, CHL: Chloramphenicol. MDR = Multi—Drug Resistance, S = Susceptible, I = Intermediate, and R = Resistance.

In isolates from diarrheic patients, only 11.7% were not resistant to any of the selected antibiotics. However; 43.8% showed Multiple Drug Resistance, resistance to at least three antibiotic classes. From these 3.1% and 0.8% of the isolates were resistant to six and seven antibiotic classes respectively (Table 6).

Table 6. Multiple antibiotic resistance patterns of STEC O157:H7 isolates from diarrheic patients.

Antibiotic Disk Total
Isolates
N (%)
Antibiogram
Isolates sensitive to all antibiotics (19) * 19 (11.7) R0
TC (5), SXT (6), AMC (3), CXM (3), CFM (1), CN (2) 20 (15.6) R1
AMC & TC (5), SXT & CIP (1), SXT & TC (10), AMC & CN (1), AMC& SXT (3), AMC & CXM (2), CXM & TC (4), CIP & CN (1), TC, CAZ & CTR (1), AMC, CTR & CXM (1) CIP, NX & TC (1), AMC, CTR & CFM (3) 33 (25.8) R2
SXT, TC & CN(1), AMC, SXT, & CIP(1), AMC, SXT & CAF(1), AMC, CXM & TC(2), SXT, TC & CN(2), AMC, CAZ & TC (1), AMC, SXT & TC(7), AMC, TC & CHL(2), AMC, CXM & CN(3), AMC, TC & CN(1), AMC, SXT & CN(1), SXT, CIP, NX & TC(1), AMC, CFM, CXM & TC(1), AMC, CAZ & CTR, CFM & CN(1), AMC, CAZ, CTR, CFM & TC(1), 26 (20.3) R3
AMC, CTR, SXT & TC(2), AMC, TC, CN & CHL(1), AMC, SXT, TC & CN(1), AMC, CXM, SXT & TC(1), AMC, CN, CHL, CAZ & CXM(2), AMC, CAZ, CXM, TC & CN(1), AMC, SXT, CIP, NX & TC(1), AMC, CAZ, CTR, CFM, SXT & TC(1), AMC, CAZ, CTR, CFM, TC & CN(1), AMC, CAZ, CFM, CXM, TC & CN(1), AMC, CTR, CFM, CXM, SXT & TC (1), CAZ, CFM, CXM, SXT, CIP, NX & TC(1), AMC, CAZ, CTR, CFM, CXM, SXT & TC(2), AMC, CAZ, CTR, CFM, CXM, SXT, CIP & NX(1) 17 (13.3) R4
AMC, CXM, SXT, TC & CHL (1), AMC, CXM, SXT, TC & CN(1), AMC, SXT, TC, CN & CHL(1), AMC, SXT, CIP, NX, TC & CN(1), AMC, CAZ, CXM, CIP, TC & CHL(1), AMC, CAZ, CXM, SXT, TC & CN(1), AMC, CAZ, CTR, CFM, SXT, CIP, NX & TC(1), AMC, CAZ, CTR, CFM, CXM, SXT, CIP, NX & TC(1) 8 (6.3) R5
AMC, CXM, SXT, TC, CN & CHL (1), AMC, CFM, SXT, CIP, NX, CN & CHL (1), AMC, CXM, SXT, CIP, NX, TC & CN (2) 4 (3.1) R6
AMC, CTR, CFM, SXT, CIP, NX, TC, CN & CHL (1) 1 (0.8) R7
Total Non-MDR 72 (56.3)
Total MDR 56 (43.8)
Total isolates 128 (100)

Key: R1: Resistance to one antibiotic class; R2: Resistance to two antibiotic classes; R3: Resistance to three antibiotic classes; R4: Resistance to four antibiotic classes; R5: Resistance to five antibiotic classes; R6: Resistance to six antibiotic classes; R7: Resistance to more than six antibiotic classes, *19 isolates had a characteristic of Sensitive and Intermediate for all the selected antibiotics. Number in bracket: the number of isolates that showed resistance to the listed antibiotic classes.

In cattle isolates, only 6.1% were not resistant to any of the selected antibiotics. However; 33.3% of the isolates showed Multiple Drug Resistance. From these 6.1% and 3.0% of the isolates were resistant to five and six antibiotic classes respectively (Table 7).

Table 7. Multiple antibiotic resistance patterns of STEC O157:H7 isolates from cattle.

Antibiotic Disk Total
Isolates
N (%)
Antibiogram
Isolates sensitive to all antibiotics (2) * 2 (6.1) R0
SXT (1), TC (3), CXM (1), CFM (1), AMC (1) 7 (21.2) R1
AMC &TC (1), SXT & CIP (2), SXT & TC (7), TC, CAZ & CTR (1), AMC, CTR & CXM (1), AMC, CTR & CFM (1) 13 (39.4) R2
AMC, TC & CN (1), AMC, CXM & TC (2) 3 (9.1) R3
AMC, TC, CN & CHL (1), AMC, SXT, TC & CN (1), AMC, CAZ, CTR, CFM, SXT & TC (1), AMC, CAZ, CFM, CXM, TC & CN (1), AMC, CAZ, CTR, CFM, CXM, SXT & TC (1) 5 (15.2) R4
AMC, CAZ, CTR, CFM, CXM, SXT, CIP, NX & TC (1), AMC, CAZ, CXM, SXT, TC & CN (1) 2 (6.1) R5
AMC, CXM, SXT, CIP, NX, TC & CN (1) 1 (3.0) R6
Total Non-MDR 22 (66.7)
Total MDR 11 (33.3)
Total isolates 33 (100)

Key: R1: Resistance to one antibiotic class; R2: Resistance to two antibiotic classes; R3: Resistance to three antibiotic classes; R4: Resistance to four antibiotic classes; R5: Resistance to five antibiotic classes; R6: Resistance to six antibiotic classes; R7: Resistance to seven antibiotic classes. * 2 isolates had a characteristic of Sensitive and Intermediate for all the selected antibiotics. Number in bracket: the number of isolates that showed resistance to the listed antibiotic classes.

Discussion

STEC O157:H7 is one cause of diarrheal disease and is mostly transmitted by cattle. Cattle are the main natural reservoirs for it [34]. This study was conducted to evaluate the prevalence and antimicrobial profiles of STEC O157:H7 isolates in diarrheic patient and their cattle. Our findings showed that among 1149 diarrheic stool samples, 128 were positive for the organism. The highest prevalence was detected among under- five children. The finding also pointed out that 11.7% of isolates from diarrheic patients and 6.1% of isolates from cattle were not resistant to any of the selected antibiotics. However; Multiple Drug Resistance from the selected antibiotic classes was found in 43.8% of diarrheic patients and 33.3% of cattle.

The overall prevalence of STEC O157:H7 in this study for diarrheic patients was 11.1%. This was in agreement with reports from Bahir Dar, Ethiopia (13.9%) [18], and Western Kenya (11.1%) [35]. However, our result was lower than those reported from Eastern Ethiopia (15.3%) [16], Eastern Cape Town, South Africa (17%) [36], and Maasai land Kenya (24.1%) [37]. On the contrary, this finding is higher than the studies reported from Gondar (1.9%) [38], Sebeta town, Ethiopia (3.2%) [13], Bishoftu town, Ethiopia (2.9%) [39], Debre Berhan cities, Ethiopia (0%) [19], Nairobi Kenya (0.2%) [40], Southern Mozambique (1.9%) [41], Morogoro Tanzania (3.6%) [42], Burkina Faso (9.67%) [43], Chattogram, Bangladesh (1.45%) [44], Sudan (5%) [45], plateau state, Nigeria (5%) [46], and France (3%) [47]. The relatively a higher prevalence of the organism found in the current finding might be because of a higher level of traditional breeding practice of animals and animal -to- human interaction in the study subjects.

In this study, STEC O157:H7 was isolated in all age groups. However, the isolation rate was high in age groups of less than 5 years i.e., 5.1% STEC O157:H7 positive from the total study population. This finding was lower than studies reported from Bahir Dar (13.9%) [18], Eastern Ethiopia (15.3%) [16], Western Kenya (11.1%) [35], and Eastern Cape, South Africa (17%) [36]. Even if, the result is lower than in other studies because of study population variation. In our study, under-five children were risk group for the infection. It is due to immature immune systems and poor in hygiene practices among children and their care givers at the time of food preparation, handling, transportation and feeding.

Hand washing habit was identified as a predisposing factor for O157:H7 infection as evidenced by multivariate analysis. Patients who had an experience of hand washing after eating were about 4 times more likely to have STEC O157:H7 infections. This finding is in line with the study reported from Bahir Dar town [18].

Consuming raw vegetables, fruits, and undercooked foods is 4 times significantly associated with the prevalence of STEC O157:H7. This finding is higher than the study done in Eastern Ethiopia [16] and Bishoftu town, Ethiopia [39]. This may be due to a high level of animal manure contamination of vegetables through untreated surface water or animal manure usage as a fertilizer.

It was found that diarrheic patients who had low monthly income were 2 times more likely to have STEC O157:H7 than those who had higher monthly income. This is because income is a key instrument in applying a preventive mechanism for the predisposing factor of STEC O157:H7 infection.

The prevalence of STEC O157:H7 in cattle was 14.4%. This is higher than the study done in Debre-Birhan, Ethiopia (0.81%) [19], Hawassa, Ethiopia (4.7%) [34], Jimma, Ethiopia (7.3%) [48], Addis Ababa Municipal Abattoir, Ethiopia (6.4%) [49], Debre-Zeit, Ethiopia (7%) [50], Sudan (8%) [45], and Nigeria (0.2%) [51]. However, it is lower than the study reported in Iraqi (91.25%) [52], and Mexico (22.03%) [39]. These variations among different studies could be attributed to differences in geographical area, and the type of samples taken since recto-anal mucosal swab sample is more sensitive than fecal sampling for determining the prevalence of STEC O157:H7 in ruminant animals [6].

The availability of cattle in the diarrheic patient house was about 3 times more likely to have STEC O157:H7 compared to the counterpart. This finding is in line with the report in Eastern Ethiopia [16], and Harare, Zimbabwe [53]. However, it was lower than the report from Germany [54]. The ruminant, especially cattle had been identified as the major reservoir of STEC O157:H7, there could be cross-infection to the diarrheic patients through either direct live animal contact or with animal manure. Animal manure can contaminate food, water, and the environment, and some studies reported that contact with cattle and living in or visiting a place with farm animals are risk factors for the incidence of STEC O157:H7 infection [55].

In this study, STEC O157:H7 isolates (n = 128) in diarrheic patients showed antibiotic resistance at varying degrees. Of all the antimicrobials tested, the highest resistance was found in tetracycline 70(54.7%), and Amoxicillin/Clavulanate 68(53,1%). Among the STEC O157:H7 isolates from cattle RAMS, the highest resistances were found in tetracycline 23(69.7%), Sulfamethoxazole/Trimethoprim 16(48.5%), and Amoxicillin/clavulanate 15(45.4%). This finding is in agreement with the report in Bahir Dar [18] but is different from Cape Town [50]. This difference may be due to differences in the practice of prescribing the selected antibiotic between the two countries and even the practice of misuse of antibiotics.

Even if, the place of defecation, level of contamination of the water source, and sharing of home with cattle were not found associated with the occurrence of STEC O157:H7. However, other researchers reported open field defecation, drinking contaminated water sources, the presence of the diarrheic person in the house, and the use of common house with ruminants including cattle as a predictor for the occurrence of STEC O157:H7 [16,56,57]. The detection of STEC O157:H7 in human and their cattle calls for further epidemiological assessment to detect the source of infection, and means of transmission, and follow a prevention system.

As to the limitations of this study, we have focused only on STEC O157:H7 strain, but other pathogenic non-STEC O157:H7 serogroups causing illnesses in human needs to be identified.

Conclusion

The present study revealed a high occurrence of STEC O157:H7 in diarrheic patients and their cattle. Age, patients with bloody diarrhea, the presence of cattle in their house, the presence of another diarrheic person in the house, and the habit of consuming raw foods were more important risk factors for STEC O157:H7 infections than their counterparts. The study also pointed out the presence of resistant STEC O157:H7 to one or more antimicrobials that may lead to a potential public threat. Generally, this study could give an insight into the prevalence of STEC O157:H7 and its public health significance associated with contact cattle, consumption of raw food, and poor personal hygienic practices. Therefore, special attention and awareness should be given to teaching the community on how to give care to ruminant animals and their home, proper sanitation measures for raw foods, and hand washing habits before preparing food, before eating, and after giving care to patients, and animals. Moreover, medical professionals and veterinarians should work together to give health education to the public concerning STEC O157:H7.

Supporting information

S1 File. Laboratory Standard Operational Procedure (SOP) (media used, laboratory procedures, and antimicrobial disks used for their interpretation).

(DOCX)

Acknowledgments

We would like to thank the University of Gondar for reviewed our study proposal and awarded ethical clearance for the study. All of the study participants, data collectors, and other staff at the respective hospitals are acknowledged for their cooperation during the data and sample collection processes.

Data Availability

All relevant data, starting from socio-demographic character, prevalence of the isolate bacteria(STEC O157:H7), associated risk factor of diarrheic patients and their cattle factors are within the manuscript and its Supporting Information files.

Funding Statement

There is no specific fund or grant for this study moreover from the authors no one was received specific salary for being a member of this study.

References

  • 1.Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The lancet. 2017;390(10100):1151–210. doi: 10.1016/S0140-6736(17)32152-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bbaale E. Determinants of diarrhoea and acute respiratory infection among under-fives in Uganda. The Australasian medical journal. 2011;4(7):400. doi: 10.4066/AMJ.2011.723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Organization WH. Diarrhoea: why children are still dying and what can be done. 2009. [Google Scholar]
  • 4.IVAC. Pneumonia & Diarrhea Progress Report 2020. International Vaccine Access Center (IVAC). 2020. [Google Scholar]
  • 5.Ryan U, Zahedi A, Paparini A. Cryptosporidium in humans and animals—a one health approach to prophylaxis. Parasite immunology. 2016;38(9):535–47. doi: 10.1111/pim.12350 [DOI] [PubMed] [Google Scholar]
  • 6.Havelaar AH, Kirk MD, Torgerson PR, Gibb HJ, Hald T, Lake RJ, et al. World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS medicine. 2015;12(12):e1001923. doi: 10.1371/journal.pmed.1001923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clinical microbiology reviews. 2013;26(4):822–80. doi: 10.1128/CMR.00022-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hickey CA, Beattie TJ, Cowieson J, Miyashita Y, Strife CF, Frem JC, et al. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Archives of pediatrics & adolescent medicine. 2011;165(10):884–9. doi: 10.1001/archpediatrics.2011.152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lim JY, Yoon JW, Hovde CJ. A brief overview of Escherichia coli O157: H7 and its plasmid O157. Journal of microbiology and biotechnology. 2010;20(1):5. [PMC free article] [PubMed] [Google Scholar]
  • 10.Lal A, Hales S, French N, Baker MG. Seasonality in human zoonotic enteric diseases: a systematic review. PLoS one. 2012;7(4):e31883. doi: 10.1371/journal.pone.0031883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Launders N, Byrne L, Jenkins C, Harker K, Charlett A, Adak G. Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009–2012. BMJ open. 2016;6(1):e009933. doi: 10.1136/bmjopen-2015-009933 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Amézquita-López BA, Soto-Beltrán M, Lee BG, Yambao JC, Quiñones B. Isolation, genotyping and antimicrobial resistance of Shiga toxin-producing Escherichia coli. Journal of Microbiology, Immunology and Infection. 2018;51(4):425–34. doi: 10.1016/j.jmii.2017.07.004 [DOI] [PubMed] [Google Scholar]
  • 13.Wondu B. Occurrence and antimicrobial resistance of E. coli O157:H7 in cattle, beef and diarrheic patients in Sebeta town. 2020. [Google Scholar]
  • 14.Mir RA, Brunelle BW, Alt DP, Arthur TM, Kudva IT. Supershed Escherichia coli O157: H7 has potential for increased persistence on the rectoanal junction squamous epithelial cells and antibiotic resistance. International Journal of Microbiology. 2020;2020. doi: 10.1155/2020/2368154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Segura A, Auffret P, Bibbal D, Bertoni M, Durand A, Jubelin G, et al. Factors involved in the persistence of a Shiga toxin-producing Escherichia coli O157: H7 strain in bovine feces and gastro-intestinal content. Frontiers in microbiology. 2018;9:375. doi: 10.3389/fmicb.2018.00375 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Getaneh DK, Hordofa LO, Ayana DA, Tessema TS, Regassa LD. Prevalence of Escherichia coli O157: H7 and associated factors in under-five children in Eastern Ethiopia. Plos one. 2021;16(1):e0246024. doi: 10.1371/journal.pone.0246024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gutema FD, Rasschaert G, Agga GE, Jufare A, Duguma AB, Abdi RD, et al. Occurrence, molecular characteristics, and antimicrobial resistance of Escherichia coli O157 in cattle, beef, and humans in Bishoftu Town, Central Ethiopia. Foodborne Pathogens and Disease. 2021;18(1):1–7. doi: 10.1089/fpd.2020.2830 [DOI] [PubMed] [Google Scholar]
  • 18.Adugna A, Kibret M, Abera B, Nibret E, Adal M. Antibiogram of E. coli serotypes isolated from children aged under five with acute diarrhea in Bahir Dar town. African health sciences. 2015;15(2):656–64. doi: 10.4314/ahs.v15i2.45 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Abdissa R, Haile W, Fite AT, Beyi AF, Agga GE, Edao BM, et al. Prevalence of Escherichia coli O157: H7 in beef cattle at slaughter and beef carcasses at retail shops in Ethiopia. BMC infectious diseases. 2017;17(1):1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Macro O. Central Statistical Agency. Ethiopia demographic and health survey. 2005. [Google Scholar]
  • 21.Bording-Jorgensen M, Tyrrell H, Lloyd C, Chui L. Comparison of Common Enrichment Broths Used in Diagnostic Laboratories for Shiga Toxin—Producing Escherichia coli. Microorganisms. 2021;9(3):503. doi: 10.3390/microorganisms9030503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.McPherson A, Dhungyel O, Ward M. Comparison of recto-anal mucosal swab and faecal culture for the detection of Escherichia coli O157 and identification of super-shedding in a mob of Merino sheep. Epidemiology & Infection. 2015;143(13):2733–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Williams I, Richardson J, Starkey A, Stansfield I. Genome-wide prediction of stop codon readthrough during translation in the yeast Saccharomyces cerevisiae. Nucleic acids research. 2004;32(22):6605–16. doi: 10.1093/nar/gkh1004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Quinn BKM P. J., Leonard F. C., Hartigan P., Fanning S., Fitzpatrick E. S. Veterinary Microbiology and Microbial Disease, 2nd Edition: Wiley-Blackwell; 2021. [Google Scholar]
  • 25.Sagar A. Bacterial Identification: Biochemical Test and Identification of E. coli. Online Microbiology Notes 2015. 2017. [Google Scholar]
  • 26.Aklilu M, Sisay T, Tefera G, Tekalign B. Identification and biotyping of Escherichia coli from diarrheic lambs in and around Debre Birhan town, Ethiopia. J Environ Anal Toxicol. 2013;3(1):6. [Google Scholar]
  • 27.Carroll AM, Cobban E, McNamara EB. Evaluation of molecular and culture methods to determine the optimum testing strategy for verotoxigenic Escherichia coli in faecal specimens. Diagnostic microbiology and infectious disease. 2016;85(1):1–5. doi: 10.1016/j.diagmicrobio.2015.12.011 [DOI] [PubMed] [Google Scholar]
  • 28.Remel RIM™ E. coli O157:H7 Latex Test kit, IFU24250, Revised July, 2020. [Available from: https://assets.thermofisher.com/TFS-Assets/LSG/manuals/IFU24250.pdf. [Google Scholar]
  • 29.Iwu CJ, Jaja IF, Iweriebor BC, Obi LC, Okoh AI. Antibiotic resistance profiles of Escherichia coli O26, O145, and O157: H7 isolated from swine in the Eastern Cape Province, South Africa. Asian Pacific Journal of Tropical Disease. 2017;7(9):553–9. [Google Scholar]
  • 30.Ningrum SG, Soejoedono R, Latif H, Arnafia W, Wibawan I. Prevalence and characterization of shiga toxin-producing Escherichia coli isolated from slaughtered qurban animal in Jakarta Province. Media Peternakan. 2016;39(2):90–4. [Google Scholar]
  • 31.Imtiaz J, Hashmi I, Saeed A, Qazi I, Arshad M. Development of PCR protocol for detection of Escherichia coli in drinking water. Water Resources Management VII; Brebbia, CA, Ed; WIT PRESS: Southhampton, UK. 2013:225–32. [Google Scholar]
  • 32.Khudor MH, Issa AH, Jassim FL. Detection of rfbO157 and fliCH7 Genes in Escherichia coli Isolated from Human and Sheep in Basrah Province. Raf J Sci. 2012;23:19–33. [Google Scholar]
  • 33.Wayne P Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI document M100–S20. 2010. [Google Scholar]
  • 34.Atnafie B, Paulos D, Abera M, Tefera G, Hailu D, Kasaye S, et al. Occurrence of Escherichia coli O157: H7 in cattle feces and contamination of carcass and various contact surfaces in abattoir and butcher shops of Hawassa, Ethiopia. BMC microbiology. 2017;17:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Rono SJ, Kakai R, Esamai F, Mibei E, Odundo E. Pathotypes and virulence markers in Escherichia coli associated with diarrhoea among HIV seropositive and seronegative children below five years in Western Kenya. 2014. [Google Scholar]
  • 36.Omolajaiye S, Afolabi K, Iweriebor B. Pathotyping and antibiotic resistance profiling of Escherichia coli isolates from children with acute diarrhea in amatole district municipality of Eastern Cape, South Africa. BioMed Research International. 2020;2020:1–10. doi: 10.1155/2020/4250165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sang WK, Boga HI, Waiyaki PG, Schnabel D, Wamae NC, Kariuki SM. Prevalence and genetic characteristics of Shigatoxigenic Escherichia coli from patients with diarrhoea in Maasailand, Kenya. The Journal of Infection in Developing Countries. 2012;6(02):102–8. doi: 10.3855/jidc.1750 [DOI] [PubMed] [Google Scholar]
  • 38.Getie M, Abebe W, Tessema B. Prevalence of enteric bacteria and their antimicrobial susceptibility patterns among food handlers in Gondar town, Northwest Ethiopia. Antimicrobial Resistance & Infection Control. 2019;8(1):1–6. doi: 10.1186/s13756-019-0566-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Alemnesh j. occurrence and antimicrobial susceptibiliy profile among e. coli o157: H7 isolated from the abattior, reatail shop and diarrheic patient in bishoftu town, east shoa Ethiopia. 2018. [Google Scholar]
  • 40.Onyango AO, Kenya EU, Mbithi JJ, Ng’ayo MO. Pathogenic Escherichia coli and food handlers in luxury hotels in Nairobi, Kenya. Travel Medicine and Infectious Disease. 2009;7(6):359–66. doi: 10.1016/j.tmaid.2009.07.005 [DOI] [PubMed] [Google Scholar]
  • 41.Mandomando IM, Macete EV, Ruiz J, Sanz S, Abacassamo F, Valles X, et al. Etiology of diarrhea in children younger than 5 years of age admitted in a rural hospital of southern Mozambique. The American journal of tropical medicine and hygiene. 2007;76(3):522–7. [PubMed] [Google Scholar]
  • 42.Raji M, Minga U, Machang’u R. Prevalence and characterization of verotocytoxin producing Escherichia coli O157 from diarrhoea patients in Morogoro, Tanzania. Tanzania Journal of Health Research. 2008;10(3):151–8. doi: 10.4314/thrb.v10i3.14355 [DOI] [PubMed] [Google Scholar]
  • 43.Konaté A, Dembélé R, Kagambèga A, Soulama I, Kaboré WA, Sampo E, et al. Molecular characterization of diarrheagenic Escherichia coli in children less than 5 years of age with diarrhea in Ouagadougou, Burkina Faso. European Journal of Microbiology and Immunology. 2017;7(3):220–8. doi: 10.1556/1886.2017.00011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Uddin MS, Rahman MM, Faruk MO, Talukder A, Hoq MI, Das S, et al. Bacterial gastroenteritis in children below five years of age: a cross-sectional study focused on etiology and drug resistance of Escherichia coli O157, Salmonella spp., and Shigella spp. Bulletin of the National Research Centre. 2021;45(1):138. [Google Scholar]
  • 45.Musa H, Shikieri A, Ahmed H, Kafi K. Isolation and identification of E-coli 0157: H7 amongst Sudanese patients with bloody diarrhea and in animals. Sudan Journal of Medical Sciences. 2010;5(2). [Google Scholar]
  • 46.Itelima J, Agina S, Ogbonna A, Nwaukwu I. The Occurrence of Escherichia Coli Serotype 0157: H7 Among Humans in Some Parts Plateau State, Nigeria. 2014. [Google Scholar]
  • 47.Pradel N, Livrelli Vr, De Champs C, Palcoux J-B, Reynaud A, Scheutz F, et al. Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. Journal of Clinical Microbiology. 2000;38(3):1023–31. doi: 10.1128/JCM.38.3.1023-1031.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Haile AF, Kebede D, Wubshet AK. Prevalence and antibiogram of Escherichia coli O157 isolated from bovine in Jimma, Ethiopia: abattoirbased survey. Ethiopian Veterinary Journal. 2017;21(2):109–20. [Google Scholar]
  • 49.Hamid M, Tefera Y, Eguale T, Worku Y. Escherichia coli O157: H7: prevalence, identification and antimicrobial resistance in cattle slaughter at Addis Ababa municipal abattior, Ethiopia. International Journal of Advanced Research in Biological Sciences. 2018;5(10):136–46. [Google Scholar]
  • 50.Kalule JB, Keddy KH, Nicol MP. Characterisation of STEC and other diarrheic E. coli isolated on CHROMagar™ STEC at a tertiary referral hospital, Cape Town. BMC microbiology. 2018;18(1):1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Mailafia S, Madubuike S, Raji M, Suleiman M, Olabode H, Echioda-Egbole M, et al. Phenotypic identification of Escherichia coli O157: H7 isolates from cattle at Suleja Abattoir, Nigeria. African Journal of Microbiology Research. 2017;11(21):845–50. [Google Scholar]
  • 52.Al-Rudha AM, Al-Rubaie E, Khalil N. Distribution of E. coli O157: H7 in fecal and urine samples of cattle. IJVM. 2016;40(1):79–82. [Google Scholar]
  • 53.Navab-Daneshmand T, Friedrich MN, Gächter M, Montealegre MC, Mlambo LS, Nhiwatiwa T, et al. Escherichia coli contamination across multiple environmental compartments (soil, hands, drinking water, and handwashing water) in urban Harare: correlations and risk factors. The American journal of tropical medicine and hygiene. 2018;98(3):803. doi: 10.4269/ajtmh.17-0521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Werber D, Behnke SC, Fruth A, Merle R, Menzler S, Glaser S, et al. Shiga toxin-producing Escherichia coli infection in Germany—different risk factors for different age groups. American journal of epidemiology. 2007;165(4):425–34. doi: 10.1093/aje/kwk023 [DOI] [PubMed] [Google Scholar]
  • 55.Friesema I, Schotsborg M, Heck M, Van Pelt W. Risk factors for sporadic Shiga toxin-producing Escherichia coli O157 and non-O157 illness in The Netherlands, 2008–2012, using periodically surveyed controls. Epidemiology & Infection. 2015;143(7):1360–7. doi: 10.1017/S0950268814002349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Treacy J, Jenkins C, Paranthaman K, Jorgensen F, Mueller-Doblies D, Anjum M, et al. Outbreak of Shiga toxin-producing Escherichia coli O157: H7 linked to raw drinking milk resolved by rapid application of advanced pathogen characterisation methods, England, August to October 2017. Eurosurveillance. 2019;24(16):1800191. doi: 10.2807/1560-7917.ES.2019.24.16.1800191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Abong’o B, Momba M. Prevalence and potential link between E. coli O157: H7 isolated from drinking water, meat and vegetables and stools of diarrhoeic confirmed and non‐confirmed HIV/AIDS patients in the Amathole District–South Africa. Journal of applied microbiology. 2008;105(2):424–31. doi: 10.1111/j.1365-2672.2008.03756.x [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Balew Arega Negatie

14 Jul 2023

PONE-D-23-13678Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, EthiopiaPLOS ONE

Dear Dr Tigist Engda

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Balew Arega Negatie, Msc,MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. Study population needs clarification. It seems similar with that of source population.

2. Exclusion criteria needs revision. Authors said they excluded patients who has been on antibiotic treatment at the time of data collection but realistically they should have excluded those who are on antibiotic treatment for the last 7 days too.

3. How antibiotics used for antimicrobial susceptibility testing were selected?

4. Where did you classified Intermediate susceptibility during data analysis? (Is it susceptible or resistant?)

5. What controls did you used for PCR?

6. Agarose gel electrophoresis image is not clear (please replace it with clear image)

7. Prevalence, risk factors and drug resistance patterns discussion were not done exhaustively (fewer literature were used for comparison purpose), and reasons given for variations of your findings with other researches seems similar throughout discussion.

8. You mentioned "Even if, the place of defecation, level of contamination of the water source, and sharing of home with cattle were not found associated with the occurrence of STEC O157:H7. However, other researchers reported it.." what do you think the reasons for this? You should explain on discussion section.

9. In Conclusion section you mentioned "...teaching the community.." do you mean health education?

10. Some references are very old (Gannon, 1997; Slutsker, 1998; Olorunshola, 2000; Zhang, 2000; Pruimboom-Brees, 2000; Raji, 2003; Naylor, 2003; Kang, 2004; Thrusfield, 2005; Bryce, 2005; Casburn-Jones, 2004; Cheesbrough, 2006; Brenner, 2005). Please replace them with latest literatures.

Reviewer #2: This is an interesting study reflecting the STEC O157:H7 in the study region and may have good input for scientific people in the area of interest. The authors conducted an extensive study, collected a large number of samples, and carried out scientifically sound bacterial assessment. However, the write up and improving the comments and suggestions is good.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Belayneh Regasa Dadi

Reviewer #2: Yes: Birhan Agmas Mitiku

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: plose one review document.doc

PLoS One. 2023 Dec 21;18(12):e0295266. doi: 10.1371/journal.pone.0295266.r002

Author response to Decision Letter 0


14 Aug 2023

August1, 2023

To: Plose one

Editor-In-Chief

From: Tigist Engda (PI and corresponding author)

Submission ID: PONE-D-23-13678

Title: Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, Ethiopia

Point by point authors’ response

First, we would like to thank and appreciate the reviewers for their critical and constructive comments. We attempted all the questions and concerns raised by chief reviewers point by point as follows:

I. JOURNAL REQUIREMENTS:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Author response: Thank you. We have followed all the PLOS One requirements.

2. Your ethics statement should only appear in the Methods section of your manuscript.

Author response: Thank you. We shifted the ethics statement to the Method section as recommended and deleted it from the other section.

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files.

Author response: Thank you. We replace the clear image as requested

II. REVIEWERS COMMENTS

Comments for Reviewer I.

Comment: Study population needs clarification. It seems similar with that of source population.

Authors response: Thank you! We have noted and explained as the source populatio Date:n is all diarrheic patients who had visited the respective Comprehensive Specialized Hospitals for medical services and their cattle. However; Those diarrheic patients who are volunteers for the study and fulfilled the requirements to be the study participants (giving informed consent and the required amount of stool samples for laboratory analysis) are the study population. Page5, line 102-105.

Comment: Exclusion criteria needs revision. The authors said they excluded patients who has been on antibiotic treatment at the time of data collection but realistically they should have excluded those who are on antibiotic treatment for the last 7 days too.

Authors response: Thank you! Yes of course; those who had taken antibiotics during the past 7 days of data collection were excluded but might be cut during the editing of the document therefore we are now corrected. Page5, line112-114.

Comment: How antibiotics used for antimicrobial susceptibility testing were selected?

Authors response: Thank you! It is a good comment, it is selected based on the Clinical and Laboratory Standards Institute (CLSI, 2022) guideline. All the selected drugs were effective for diarrheal diseases caused by E. coli. However, we include norfloxacin which can be used as an effective drug for the treatment of diarrheagenic E. coli (Msolo Luyanda; et al; 2020). In other selected drugs, there is at least one drug frequently prescribed to treat diarrheal diseases caused by bacteria in their class, so we are trying to check the resistance rate of drugs in each class of antimicrobials. (Ref: “Msolo L, Iweriebor B C, Okoh A I. Antimicrobial Resistance Profiles of Diarrheagenic E. coli (DEC) and Salmonella Species Recovered from Diarrheal Patients in Selected Rural Communities of the Amathole District Municipality, Eastern Cape Province, South Africa. Dovepress journal Infection and Drug Resistance, 2020:13 4615–4626”).

Comment: Where did you classify Intermediate susceptibility during data analysis? (Is it susceptible or resistant?)

Authors response: Thank you for the concern. Intermediate susceptibility was small in number and included as sensitive.

Comment: What controls did you use for PCR?

Authors response: Thank you! We have noted and corrected it as ‘‘A negative control was performed by adding 10 µl of sterile deionized water; a positive control was performed by adding 1.25µl of known DNA sample (STEC O157:H7; ATCC 43895)’’. Page 10, lines 212-214

Comment: The agarose gel electrophoresis image is not clear (please replace it with a clear image).

Authors response: Thank you! for the comment, it has been replaced by a clear image.

Comment: The prevalence, risk factors, and drug resistance patterns discussion was not done exhaustively (fewer literature were used for comparison purposes), and the reasons given for variations of your findings with other research seems similar throughout the discussion.

Authors response: Thank you! Even though there are not much more studies done in our country for comparison. We are now revised.

Comment: You mentioned "Even if, the place of defecation, level of contamination of the water source, and sharing of home with cattle were not found associated with the occurrence of STEC O157:H7. However, other researchers reported it." what do you think are the reasons for this? You should explain in the discussion section.

Author response: Thank you! for your logical question. First of all, when we see the socio-demographical characteristics of the study population, only 25.7% of STEC O157: H7 positive patients shared their home with cattle, and the remaining (74%) do not. From this data, we cannot expect an association. However, in studies were higher results of sharing a home with cattle, there may be an association and the reason can work. Similarly, in surface water sources and open field defecation was detected in 3.9% and 22.7% of STEC O157:H7 positive respectively, and has no association. This may be due to less positive isolate.

9. Comment: In the Conclusion section you mentioned "...teaching the community." do you mean health education?

Author response: Yes. It means health education.

Comment: Some references are very old (Gannon, 1997; Slutsker, 1998; Olorunshola, 2000; Zhang, 2000; Pruimboom-Brees, 2000; Raji, 2003; Naylor, 2003; Kang, 2004; Thrusfield, 2005; Bryce, 2005; Casburn-Jones, 2004; Cheesbrough, 2006; Brenner, 2005) and MacFaddin JF,2000. Please replace them with the latest literature.

Author response: Thank you. The comment is accepted and replaced by other references.

Comments for Reviewer II.

This is an interesting study reflecting the STEC O157:H7 in the study region and may have good input for scientific people in the area of interest. The authors conducted an extensive study, collected a large number of samples, and carried out scientifically sound bacterial assessments. However, the write-up and improving the following comments and suggestions is good.

1. Comment: Did the author clarify: Page 2 line number 29…………………Ethiopia from December/2020 to May/2022. Page 4 line 89……………from December 2020 to June 2022. Which one was the exact study period?

Authors response: Thank you for the comment. we have noted and the correct one is December 2020 to June 2022. So, it is corrected in the text as’’ December 2020 to June 2022’’.

2. Comment: Line 89: study was carried out……. from December/2020 to May/2022. A total of 1,149 Diarrheic stool samples and 229 cattle Recto-anal mucosal swab samples were collected.” The samples were collected over one year, meaning at different seasons of the year. Did you consider the effects of season on the disease level?

thor’s response: Yes, they are different since around half of human cases are sporadic with a seasonal pattern favoring spring and summer. Also, in this study, 49.2% and 25.8% of STEC O157:H7 isolate was detected in the summer and spring seasons respectively.

3. Comment: The description of the sampling strategy is not clear. Page 6, line 116 Authors wrote that …………… The study participants were selected using simple random sampling techniques. How could be? Because the study is an institution based; that means diarrheic patients is not known their names before visiting the hospital. Or may not wait for you after they gain service, they leave the hospital except admit ones. So, how can list their name and lottery then sample? Can Authors clarify? I think you mean systematic random sampling????

Author’s response: Yes, the comment is well accepted and corrected as” A simple random sampling technique was used to select Comprehensive Specialized Hospitals. However, the study participants were selected using systematic random sampling techniques”. Page6, line 122and 121.

4. Comment: Page 6 line numbers 118-120; Twelve-month diarrheic cases were taken from the patient registration book in order to project t2e probable case flow in each hospital per day. Then the study subjects were recruited consecutively until the desired sample was reached. Is not clear; Can Authors elaborate in figures/numbers to clarify the readers?

Authors response: Thank you! We accepted the comment and corrected it on page 6, lines 122-136.

5. Comment: In the case of cattle, convenient sampling techniques were used. All cattle found in STEC O157:H7-positive houses were included in the study and were found 229. Not clear; do you mean convenient sampling? Or census/all cattle sample?

Since hospital service users come from a distance even from politically unstable areas; so, how do you trace back to their cattle to include all cattle in positive houses? E.g. Beshangule gumize, Jawi to Felghiwote hospital, Afar region to Dessie hospital etc…

Authors response: Yes. the comments are well accepted and corrected as ‘’all cattle found in the STEC O157:H7 positive houses were included in the study.’’ Page 6, lines 132 to 134. Of course, geographical distribution (highly remote areas), and politically unstable areas are challenges to achieved the plan of sample collection. However, in our study, the cattle used for sample collection are around the selected hospital. this means; it is not as far or remote. In addition; the specific house was found with the help of animal science personnel at the site and registered STEC O157:H7 positive diarrheic patient profile (Name, phone no., specific name of the site (kebele name, ‘Gote’ name)).

6. Comment: A scholar suggests???? E. coli is may originated from human, or other animal feces not only cattle.” I’m afraid how to handle another source of infection other than cattle. E.g. sheep, dogs, other non-diarrheic humans etc…

Authors response: Thank you! of course, animals, other than cattle and asymptomatic humans (non-diarrheic humans) can be the source of STEC O157:H7. So, to manage the distribution of STEC O157:H7, we have to prevent the root of transmission by eating cooked and non-contaminated food, having proper contact with animals and also human

7. Comment: Page 12 line 257…………..categorical variables, univariable and multivariate analysis with a 95% confidence interval (CI)………………change by categorical variables, bi-variable and multivariable logistic regression analysis with 95% confidence interval(CI)……………………. Because to make uniformity, and multivariate analysis and multivariable analysis are quite different.

Author’s Response: Yes, multivariate analysis and multivariable analysis are completely different and the comment is well taken and corrected in the main document.

8. Comment: Page 29 your conclusion part line # 421-422 Shiga toxin-producing E. coli O157:H7 isolates developed drug resistance to most antimicrobials tested. Giving antibiotic treatment in E.coli infection of humans and animal causes worse of the disease thus not recommended; despite this, where is the drug resistance come from?

Authors response: It is a good comment. In most laboratory setups of the country, the specific bacterial organism that causes diarrhea has not been identified rather is reported as bacteria if there are pus cells in the field. Based on this simple report, the prescriber just prescribes any of the antibiotics that are available in health institutions. Therefore; the patient may be repeatedly exposed to these antibiotics and due to lack of knowledge, most patients did not have the habit of taking medicine completely which altogether contributes to the development of resistance. Another possibility is that mutant bacteria may be directly reached to the patient and consequently cattle can consume these mutant bacteria or vice versa.

Comment: In addition, u tested the number of antibiotics that are ban and not used in animals? E.g., Chloramphenicol; what is the reason for the discrepancy?

Authors response: Thank you! for the comment. Even though sensitivity tests had been done for banned antibiotics in cattle, it still gives a clue that the cattle can consume the already resistant bacteria for the drug. It also gives information on the transmission of STEC O157:H7 from humans, the environment, plants, soil, and water to animals.

We thank all the reviewers for giving comments and supportive suggestions in order to improve the paper!

Please note all the corrections made were labeled in red color in the main text.

With best regards

Tigist Engda (PI and corresponding author)

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Balew Arega Negatie

1 Oct 2023

PONE-D-23-13678R1Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, EthiopiaPLOS ONE

Dear Dr. Engda,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 15 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Balew Arega Negatie, Msc,MD

Academic Editor

PLOS ONE

Additional Editor Comments:

Dear author

Your manuscript needs further and extensive work before we consider it for publication. I attached my comments and suggestions as highlighted in the main manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Belayneh Regasa Dadi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Manuscript.docx_shigella.pdf 333.pdf

PLoS One. 2023 Dec 21;18(12):e0295266. doi: 10.1371/journal.pone.0295266.r004

Author response to Decision Letter 1


29 Oct 2023

Thank you ,

we have been attached the academic editor( Balew Arega Negatie, Msc,MD) and reviewer (Dr. Belayneh Regasa Dadi) comments with specific response one by one.

Date: October 18, 2023

To: Plose one

Editor-In-Chief

From: Tigist Engda (PI and corresponding author)

Submission ID: PONE-D-23-13678

Title: Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, Ethiopia

Point by point authors’ response

First, we would like to thank and appreciate the reviewers for their critical and constructive comments. We attempted all the questions and concerns raised by academic editors and reviewers. We used red font color for changes.

I. ACADEMIC EDITOR’S COMMENTS:

1. Comment: Please include the following items when submitting your revised manuscript:

• A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

• A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

• An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'

Author response: Thank you! We have included all items; the rebuttal letter (Response to Reviewers), a marked-up copy of the manuscript with file name “Revised Manuscript with Track changes” and unmarked version of the original file with file name “Manuscript” are attached and you are kindly requested to upload these files.

2. Comment: Your manuscript needs further and extensive work before we consider it for publication. I attached my comments and suggestions as highlighted in the main manuscript

Authors response: Thank you! We have noted and corrected it point by point in the manuscript and manuscript with track changes.

2.1. Comment: Line 37: make it ‘‘under five children’’.

Author response: Thank you! the comment is well accepted and corrected it on page 2, line 37.

2.2. Comment: Line 38 &39, patients with bloody diarrhea 39 (AOR:4.09, 95%CI:2.09-8.00). This is the manifestation of the disease how does it become a risk factor?

Author response: Thank you! for the comment and corrected it on page 2, line 39. But what we want to show is the distribution of the organism with patient’s stool appearance and actually it is the problem of write up and were not the place here and removed.

2.3. Comment: Line 57: Delete the word ‘to’

Author response: Thank you! we have noted and corrected it on page 3, line 57

2.4. Comment: Line 59: The word ‘which’ change by ‘that’

Author response: Thank you! for the comment and corrected it on page 3, lines 59

2.5. Comment: line 105: The word ‘Those’ change by ‘These’

Author response: Thank you! we have noted and corrected it on page 5, line 104.

2.6. Comment: line115: The word ‘that’ change by ‘who’.

Author response: Thank you! for the comment and corrected it on page 6, line 111.

2.7. Comment: line 137: add the word ‘the’.

Author response: Thank you. We accepted the comment and corrected it on page 7, line132

2.8. Comment: line 155: What is this?

Author response: Thank you! we have noted that the number 2 was deleted in mistake during editing and corrected it on page 7, line 150 as “2gm”.

2.9. Comment: line 199: Correct this.

Author response: Thank you! for reading critically it was the bracket that indicates the reference number that we take during first draft writing and now it is removed and corrected on page 9, line 194 as “analysis”.

2.10. Comment: line 243: The word ‘became’ change to ‘were’.

Author response: Thank you! We have noted and corrected it on page 11, line 235.

2.11. Comment: line 246: The word ‘placing’ change to ‘placed’.

Author response: Thank you! for the comment and corrected it on page11, line 238.

2.12. Comment: line 249: Put clear definition of MDR.it means to be resistance to all

mentioned?

Author response: Thank you! for the comment. No, it does not mean to be resistance to all the selected antibiotics. However, Multiple Drug Resistance is defined as “resistance to at least three antibiotic classes”. It is defined in page 12, line 241. These classes of antibiotics are listed on page 12, line 242-246

2.13. Comment: line 265: Delete the word ‘one’.

Author response: Thank you! we have rewrite it as “a week prior to data collection” on page 12, line 257.

2.14. Comment: line 270: Delete the word ‘own’.

Author response: Thank you! for the comment and we have corrected it on page 12, line 262.

2.15. Comment: line 281:is it colonization or infection? Specially among diarrheic patients.

Author response: Thank you! we have noted and corrected it on page 13, line 272

as “infection”.

2. 16. Comment: line 294: The word ‘explained’ change to ‘explaining’.

Author response: Thank you! for the comment and we corrected it on page 13, line 284.

2.17. Comment: line 298: ‘in order to’ change to’ to’

Author response: Thank you.! we have noted and corrected it on page 14, line 288.

2.18. Comment: line 312: This idea (…However, from 187 diarrheic patients, only 53 study participants were positive for STEC O157:H7 which had a total of 229 cattle with 124 cows, 46 oxen, and 59 calves) good to take it to the prevalence subtitle below.

Author response: Thank you! we have noted and shifted it to under the subtitle of Prevalence of shiga toxin-producing Escherichia coli O157:H7 on page 16, line 311-314.

2.19. Comment: line 318: The word ‘sample’ change to ‘samples.’

Author response: Thank you! for the comment and we have corrected it on page 16, line 303.

2.20. Comment: line 320-323: These sentences are repeated several times. Please summarize to

avoid repetition and add CI.

Author response: Thank you. We have noted and rewrite it on page 16, line 303-306. as “of the total stool samples, 128 stool samples were positive for STEC O157:H7 with rfb O157 and flic H7 genes in PCR with agarose gel Electrophoresis tested (Table1). As a result, the overall prevalence was 11.1% (95% CI: 0.09-0.13)”.

2.21. Comment: line 328: Please include the details as a supplementary, which cattle, how many cattle from single index diarrheic patient.

Author response: Thank you! for the comment and detailed explanation about cattle have discussed on page 16, line from 312 to 317.

2.22. Comment: line 330-334: re-summarize the sentence “there were 33 isolates which has rfb O157 genes. These rfb O157 positive isolates were tested for the presence of flic H7 gene. All the 33 isolates in cattle had both rfb (157 and flic H7 as a result the overall prevalence of STEC O157:H7 in cattle was 33/229 (14.4%; 95%CI:0.39-0.52).

Author response: Thank you! the sentence is re-summarized on page 16, line 315-318.

2.23. Comment: line 339: insert ‘a’ in front of higher.

Author response: Thank you! we have noted and corrected in page 18, line 326.

as ‘a higher’.

2.24. Comment: line 340: rewrite ‘the age group of under 5’ to ‘among under 5 children’.

Author response: Thank you! for the comment and we have rewrite it on page 18, line 327.

2.25. Comment: line 355: Please remove variables that did not full fill your eligibility criteria (p<0.25), because has no importance here.

Author response: Thank you! We accepted the comment and corrected it on page 19-21. Table 4. We removed the variables that did not full fill the eligibility criteria.

2.26. Comment: in table 4, (stool appearance variable): This is difficult to interpret it is an established fact that E.coli O157:H7 is invasive and causes bloody diarrhea. Manifestation can not be the risk factor for the given disease please avoid.

Author response: Thank you! we accepted the comment and removed stool appearance in the analysis from Table 4. However; it was analyzed in percent to know the distribution of the organism with patient’s stool appearance and explained under the prevalence subtitle.

2.27. Comment: line 377: Table6 is only for human not from cattle

Author response: Thank you! yes, table 6 is only for human and corrected it on page 23, line 359-362. Of-course, it is editing problem. However, the description for cattle has its place page 24, line 362 and Table 7.

2.28. Comment: line 383: This table is hard to understand? It is not simple, it is complex, for the table 6. Please write short summary in sentences and take them to supplementary, be sure also that, these tables give more information not included in the table 5.

Author response: Thank you! for the comment and incorporated brief summary on page 23, line 359-362. Table 5 indicates the susceptibility profile for STEC O157:H7 isolates from diarrheic patients and their cattle however Tabel 6 indicates antibiogram and there is no repetition.

2.29. Comment: in table 6 of the second row: what is this? title is Antibiotics disk.

Author response: Thank you! for the comment. It is not title but it is a total number of isolates in diarrheic patients. However, it is now removed because it is already written at the bottom of the table 6.

2.30. Comment: in the table 6, from the third to last rows: What this numbers means? Similar to others?

Author response: Thank you! we have noted and discussed it on page 24, line 368-369 as “Number in bracket: the number of isolates which showed resistance to the listed antibiotic classes’’ (page 24, line 368-369). For example, table 6, row 3, “TC (5)”, this means five isolates showed resistance for only tetracycline. Row 4 “AMC, TC (5)” this means 5 isolates showed resistance to amoxicillin/clavulanic acid and tetracycline. Since these two drugs are from different antibiotic classes therefore their antibiogram categorization is R2.

2.31. Comment: line 390: Table7 is only for human not from cattle

Author response: Thank you! Yes, table 7 is only for cattle and corrected it on page 24, line 372. Of-course, it is editing problem.

2.32. Comment: line 390: This table is hard to understand? It is not simple, it is complex, for the table 7. Please write short summary in sentences and take them to supplementary, be sure also that, these tables give more information not included in the table 5.

Author response: Thank you! for the comment and incorporated brief summary on page 24, line 370-372. Table 5 indicates the susceptibility profile for STEC O157:H7 isolates from diarrheic patients and their cattle however Table 7 indicates antibiogram and there is no repetition.

2.33. Comment: in table 7 second row what is this? title is Antibiotics disk. row

Author response: Thank you! for the comment. It is not title but it is a total number of isolates in cattle. However, it is now removed because it is already written at the bottom of table 7.

2.34. Comment: in table 7 from third to last rows: What this numbers means? Similar to others?

Author response: Thank you! we have noted and give an explanation on page 26, line 378-379 as “Number in bracket: the number of isolates which showed resistance to the listed antibiotic classes’’(page26,line 378-379). For example, table 7, row 3 “SXT (1)” this means one isolate is resistance to only Sulfamethoxazole/Trimethoprim. Row 4 “AMC, TC (1)” this means 1 isolate showed resistance to amoxicillin/clavulanic acid and tetracycline. Since these two drugs are from different antibiotic classes therefore from the antibiogram, they are categorized as R2.

2.35. Comment: line 398. Please in the first paragraph include the short summery of your main findings.

Author response: Thank you! for the comment. We have included summery of our main findings on page 26, line 381-388.

2.36. Comment: line 407-410. This is a very general explanation rather than comparing numbers. Interpret your findings apply throughout your discussion

Author response: thank you! we have noted and corrected though out the discussion on page 26-28.

2.37. Comment: line 420. Please remove the AOR, CI and P-value from your discussion part. Do for the rest.

Author response: Thank you! for the comment. We have seen and removed AOR, CI and P-value in discussion part.

2.38. Comment: line 436: change the word ‘in applying’ by ‘to apply’.

Author response: Thank you! for the comment and we have deleted the word ‘in applying’ and replace by ‘to apply’ on page 27, line 419.

2.39. Comment: line 452 and 553: remove the word since and even.

Author response: Thank you! for the comment and we have deleted the word “since” before animal on page 28, line 434 and “even” before some on page 28, line 435 respectively.

2.40. Comment: Line 469. Please include the limitation of the study

Author response: Thank you! for the comment. We have incorporated the limitation of our study on page 29, line 452-453

2.41. Comment: replace the word “for” by “to”, “for” by “to”, “of” by “to” and remove the word “on” in page29, line 463, 463, 464, and 463 respectively.

Author response: Thank you! for the comments. we accept the comments and corrected on page 29, line 463.

� In general, we have tried to edit the whole body of the paper.

� We thank all the academic editors and reviewers for giving comments and supportive suggestions in order to improve the paper!

Please note all the corrections

With best regards!

Tigist Engda (PI and corresponding author)

Attachment

Submitted filename: Response to academic Editors-R3.docx

Decision Letter 2

Balew Arega Negatie

10 Nov 2023

PONE-D-23-13678R2Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, EthiopiaPLOS ONE

Dear Dr. Engda,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it needs  minor modification  to fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Please insert comments here and delete this placeholder text when finished. Be sure to:

  • Indicate which changes you require for acceptance versus which changes you recommend

  • Thank you addressing all comments and suggestions in the previous version. Here , I attached some minor comments as track change in the main manuscript

Please submit your revised manuscript by Dec 25 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

We look forward to receiving your revised manuscript.

Kind regards,

Balew Arega Negatie, Msc,MD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Manuscript.pdf

PLoS One. 2023 Dec 21;18(12):e0295266. doi: 10.1371/journal.pone.0295266.r006

Author response to Decision Letter 2


13 Nov 2023

Date: November 12, 2023

To: Plose one

Editor-In-Chief

From: Tigist Engda (PI and corresponding author)

Submission ID: PONE-D-23-13678 R2

Title: Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, Ethiopia

Point by point authors’ response

First, we would like to thank and appreciate the reviewers for their critical and constructive comments. We attempted all the questions and concerns raised by academic editors.

ACADEMIC EDITOR’S COMMENTS:

1. Requirement at time of submitting revised manuscript:

Please include the following items when submitting your revised manuscript:

• A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

• A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

• An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Author response: Thank you! We have included all items; the rebuttal letter (Response to Reviewers), a marked-up copy of the manuscript with file name “Revised Manuscript -R4 with Track changes” and unmarked version of the original file with file name “Manuscript” are attached and you are kindly requested to upload these files.

II. Comment: Please insert comments here and delete this placeholder text when finished.

Be sure to:

1. Indicate which changes you require for acceptance versus which changes you recommend

Authors response: Thank you. We consider it.

2. Thank you for addressing all comments and suggestions in the previous version. Here, I attached some minor comments as track changes in the main manuscript.

Author response: Thank you. We have noted and corrected it point by point in the manuscript and manuscript-R4 with track changes.

2.1. Comment: Line 48: the word ‘continues’ change by ‘continued’

Author response: Thank you for the comment and corrected it on page3, line 48.

2.2. Comment: Line 173: The word ‘which’ change by ‘that’

Author response: Thank you. We have noted and corrected it on page 8, line 171.

2.3. Comment: Line 206: The word ‘encoded’ change by ‘encoding’

Author response: Thank you. We have noted and corrected it on page 10, line 204.

2.4. Comment: Line 223: add the letter ‘a’ before the word gel.

Author response: Thank you for the comment and corrected it on page 10, line 220.

2.5. Comment: Line 243: Delete the word ‘by’.

Author response: Thank you for the comment and corrected it on page11, line 238.

2.6. Comment: Line 262: The word ‘prior to’ change by ‘before’ and add the word ‘the’ before training.

Author response: Thank you. We have noted and corrected it on page 12, line 257.

2.7. Comment: Line274-276: sentences state in this line and the sentences on line 273-274 are opposites; please remove this one. You only variables with p<0.2 in bivariate to multivariable regression.

Author response: Thank you. We accepted the comment and corrected it on page 13. Line 267-270.

2.8. Comment: Line 281: edit the word ‘lemeshow’ by ‘Lemeshow’

Author response: Thank you for the comment and corrected it on page 13, line 274.

2.9. Comment: Line 290: Delete the word on

Author response: Thank you for the comment and corrected it on page13, line 282.

2.10. Comment: Line 293: Delete H7

Author response: Thank you for the comment. We were communicated with those who were STEC O157:H7 positive patients not all STEC O157 positive patients. Basically, STEC O157:H7 is one group of the STEC O157. So, it should be stated as STEC O157:H7. Because our aim is to find out only STEC O157:H7.

2.11. Comment: Line 319: The word ‘from’ change by the word ‘of’

Author response: Thank you. we are corrected on page 16, line 313.

2.12. Comment: Line 322: the word ‘swabs’ change to ‘swab’

Author response: Thank you. we are corrected on page16, line 315.

2.13. Comment: Line 334 and 335: the word ‘were’ and resident change by ‘was’ and ‘residents’ respectively

Author response: Thank you. We are corrected on page 18. Line 327 and 328 respectively.

2.14. Comment: Line 347, table 4: What is the value of AOR for drinking water source and drinking water treatment?

Author response: Thank you. We are now incorporated the AOR value of drinking water source and drinking water treatment on page 20, line 340 in table 4.

2.15. Comment: Line 347, table 4: why do you include this variable in Multivariable regression because the p value is greater than your selection criteria, P<0.2 in History of hand washing habit independent variable.

Author response: Thank you for the comment. The P-value of after eating, one of the categories under History of hand washing habit variable, is (0.00) which is less than 0.2. and needs to calculate Multivariable regression to know it’s association. Similarly drinking water treatment variable too.

2. 16. Comment: Line 377: change the word ‘which’ by ‘that’.

Author response: Thank you. We are corrected on page 24, line 369.

2.17. Comment: Line 380: change the word ‘antibiotics’ to ‘antibiotic’.

Author response: Thank you and corrected on page 24, line 372

2.18. Comment: Line 393: delete the word ‘and” before the highest.

Author response: Thank you and corrected on page 26, line 385.

2.19. Comment: Line 393: add hyphen b/n under and five.

Author response: Thank you and corrected on page 26, line 385.

2.20. Comment: line 394: add the word ‘of’ after 11.7% and after 6.1%.

Author response: Thank you and corrected on page 26, line 386.

2.21. Comment: Line 396: change the word ‘were’ by ‘was.

Author response: Thank you and corrected on page 26, line 388.

2.22. Comment: Line 407: Change the word ‘traditionally’ to ‘traditional’.

Author response: Thank you and corrected on page 26, line 398.

2.23. Comment: Line 413: change the word ‘to’ by ‘in’.

Author response: Thank you and corrected on page 26, line 404.

2.24. Comment: line 414: add hyphen after the word ‘under’, change the word ‘was’ by ‘were’ and ‘to’ by ‘for’.

Author response: Thank you and corrected on page 27, line 405.

2.25. Comment: line 415 and 416: add ‘s’ to the word system and practice and the before time.

Author response: thank you and corrected on page 27, line 406.

2.26. Comment: Line 419: the word had been changed by were.

Author response: Thank you and corrected on page 27, line 409.

2.27. Comment: Line 421: change the word ‘are’ by ‘is’.

Author response: Thank you and corrected on page 27, line 412.

2.28. Comment: Line 426: change the word was by were.

Author response: Thank you and corrected on page 27, line 417.

2.29. Comment: Line 434: add the word ‘and’ before Mexico and Line 435: add the word ‘and’ before the type of samples.

Author response: Thank you and corrected on page 28, and line 425 and 426.

2.30. Comment: Line 451: Delete the word ‘in’ before different.

Author response: Thank you and corrected on page 28, line 442.

2.31. Comment: Line 460: add word ‘and’ before means, ‘comma’ after transmission and ‘a’ before prevention.

Author response: Thank you. we have incorporated the word “and” before the word “means” added comma after transmission and “a” before prevention. Page 29, line 451.

2.32. Comment: Line 473: add ‘ing’ to the word ‘teach’

Author response: Thank you and corrected on page 29, line 463.

2.33. Comment: Line 475: add the word ‘and’ before the word after

Author response: Thank you and corrected on page 29, line 465

2.34. Comment: Line477: change the word ‘with respect to’ by ‘concerning’.

Author response: Thank you and changed the word on page 29, line 466.

NB: We appreciate the academic editors for critically checked the manuscript and giving us valuable comments and of course we have tried to attempt all the comments.

With best regards!

Tigist Engda (PI and corresponding author)

Attachment

Submitted filename: Response to Reviewers-R4.docx

Decision Letter 3

Balew Arega Negatie

20 Nov 2023

Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, Ethiopia

PONE-D-23-13678R3

Dear Dr. Tigist

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Balew Arega Negatie, Msc,MD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Balew Arega Negatie

12 Dec 2023

PONE-D-23-13678R3

PLOS ONE

Dear Dr. Engda,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Balew Arega Negatie

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Laboratory Standard Operational Procedure (SOP) (media used, laboratory procedures, and antimicrobial disks used for their interpretation).

    (DOCX)

    Attachment

    Submitted filename: plose one review document.doc

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Manuscript.docx_shigella.pdf 333.pdf

    Attachment

    Submitted filename: Response to academic Editors-R3.docx

    Attachment

    Submitted filename: Manuscript.pdf

    Attachment

    Submitted filename: Response to Reviewers-R4.docx

    Data Availability Statement

    All relevant data, starting from socio-demographic character, prevalence of the isolate bacteria(STEC O157:H7), associated risk factor of diarrheic patients and their cattle factors are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES